Drug distributor and wholesaler McKesson has expanded in the past couple of years, doing deals as it has followed competitor AmerisourceBergen in muscling up internationally. Now it will contract, whacking about 1,600 jobs.
Teva Pharmaceuticals' efforts to cut costs by making its manufacturing more efficient have landed at a plant in the U.K. where the generics leader will cut dozens of jobs but add some new positions with more specialized skills.
Orlando-based Nephron Pharmaceuticals will cut another 250 positions in Florida as it transfers its manufacturing to a newer site in South Carolina.
Perrigo, in an effort to hive off $175 million a year in costs, is laying off 6% of its workforce, among other steps.
The job cuts at Merck have been massive ever since its 2009 merger with Schering-Plough, 36,000 in 5 years. They have almost run their course, but manufacturing will make up most of what is left as it continues to shed manufacturing plants.
Healthcare was one of the strongest segments at German conglomerate Siemens last quarter, both in terms of sales growth and profitability. That could help insulate this business, comprised mostly of imaging and diagnostics, from an ongoing restructuring that aims to trim employees and costs from its worst performing businesses.
Zimmer will close its Carlsbad, CA, dental headquarters following its looming $13 billion merger with Biomet, resulting in an unspecified number of layoffs. The plant closure will occur in 12 months, say internal company emails sent to both companies' employees that were obtained by FierceMedicalDevices.
Japan's Eisai has decided to follow the cost-cutting trend of many of its multinational counterparts and lay off a quarter of its U.S. commercial and regional corporate services units, which currently employ about 850 people. The unit said the 200-plus staff reductions would not affect manufacturing or R&D units.
Ophthalmic and surgical sutures for holding tissue together after medical procedures will no longer be made in Exeter Township, PA, thanks to the upcoming closure of the Surgical Specialties' manufacturing plant in the Philadelphia suburb. It will come at a cost of 254 jobs.
Surgical Instrument provider Integra LifeSciences laid off 49 employees in Massachusetts as part of a cost-saving initiative, MassDevice reports, citing a public notice filed under the federal Worker Adjustment and Retraining Notification Act.